At a glance
- Originator NPS Allelix
- Class Small molecules
- Mechanism of Action Nerve growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain
Most Recent Events
- 12 Dec 2002 Discontinued - Preclinical for Neuropathic pain in USA (unspecified route)
- 15 Feb 2000 Preclinical development for Neuropathic pain in USA (Unknown route)